TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
VCYT

Veracyte Inc

Healthcare · Diagnostics & Research

40.60$ +5.4% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Veracyte Inc (VCYT): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.

Next report 11/03/2026
Last report 07/30/2026
Earnings surprise by quarter (%)
Q3 23 · -215.4 % 23 Q4 23 · -333.3 % 23 Q1 24 · 140.0 % 24 Q2 24 · 3,100.0 % 24 Q3 24 · 94.1 % 24 Q4 24 · 40.0 % 24 Q1 25 · 55.0 % 25 Q2 25 · 46.7 % 25 Q3 25 · 59.4 % 25 Q4 25 · 35.9 % 25 Q1 26 · 57.6 % 26 Q2 26 · 27.6 % 26

EPS estimate beaten

Full history 32 of 51 quarters (63%)
Last 16 quarters 13 of 16 quarters (81%)

Earnings Call Transcripts

Search all transcripts →

  • 05/05/2026 Earnings Call Q1 2026 Open →
  • 02/25/2026 Earnings Call Q4 2025 Open →
  • 11/04/2025 Earnings Call Q3 2025 Open →
  • 08/07/2025 Earnings Call Q2 2025 Open →
  • 05/08/2025 Earnings Call Q1 2025 Open →
  • 02/24/2025 Earnings Call Q4 2024 Open →
  • 11/06/2024 Earnings Call Q3 2024 Open →
  • 08/06/2024 Earnings Call Q2 2024 Open →
  • 05/07/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 09/14/2026 VERACYTE, INC. (VCYT): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/30/2026 VERACYTE, INC. (VCYT): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?